Price
Target price
€25.30
€25.30
-1.170%
-0.3
-1.170%
€31.75
09:30 / Tradegate
WKN: 883035 / Symbol: TEVA / Name: Teva Pharma / Stock / Pharmaceuticals / Large Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Teva Pharmaceutical Industries Ltd ADR Stock
We can see a decrease in the price for Teva Pharmaceutical Industries Ltd ADR. Compared to yesterday it has lost -€0.300 (-1.170%).
With 22 Buy predictions and not a single Sell prediction Teva Pharmaceutical Industries Ltd ADR is an absolute favorite of our community.
With a target price of 31 € there is a positive potential of 22.53% for Teva Pharmaceutical Industries Ltd ADR compared to the current price of 25.3 €.
Our community identified positive and negative aspects for Teva Pharmaceutical Industries Ltd ADR stock for the coming years. 3 users see the criterium "Worthwhile Investment for the next years" as a plus for the Teva Pharmaceutical Industries Ltd ADR stock. On the other hand our users think that "Conscious of the environment" could be a problem in the future.
Pros and Cons of Teva Pharmaceutical Industries Ltd ADR in the next few years
Pros
?
S********** s********
?
W********* I********* f** t** n*** y****
?
B****
Cons
?
C******** o* t** e**********
?
G***** c******* t* c**********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Teva Pharmaceutical Industries Ltd ADR vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Teva Pharmaceutical Industries Ltd ADR | -1.170% | -5.882% | -10.490% | 70.100% | -4.833% | 219.202% | 174.384% |
| Bayer AG ADR | -4.900% | 3.209% | -20.902% | 73.874% | 9.659% | -30.072% | -26.336% |
| Novartis AG ADR | -0.740% | -3.226% | -2.527% | 35.000% | 13.924% | 73.077% | 86.207% |
| UCB S.A. | 0.040% | -1.770% | -9.081% | 41.873% | 7.540% | 219.765% | 220.407% |
Comments
Teva Pharmaceutical Industries (TEVA) had its "overweight" rating reaffirmed by Piper Sandler. They now have a $41.00 price target on the stock, up from $40.00.
Show more
Ratings data for TEVA provided by MarketBeat
Teva Pharmaceutical Industries (NYSE:TEVA) had its price target raised by analysts at Truist Financial Corporation from $38.00 to $42.00. They now have a "buy" rating on the stock.
Show more
Ratings data for TEVA provided by MarketBeat
Teva Pharmaceutical Industries (NYSE:TEVA) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $36.00 to $45.00. They now have a "buy" rating on the stock.
Show more
Ratings data for TEVA provided by MarketBeat